# Active learning for energy-based antibody optimization and enhanced screening

arXiv: https://arxiv.org/abs/2409.10964 · HTML: https://mlsanity.com/paper/2409.10964/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 5 of its 35 references that are in the map.
- First posted on arXiv 17 Sep 2024.

## Builds on (most cited first, 5 of 5)

- [UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction](https://mlsanity.com/paper/1802.03426/) (2018)
- [AbDiffuser: Full-Atom Generation of in vitro Functioning Antibodies](https://mlsanity.com/paper/2308.05027/) (2023)
- [Antibody-Antigen Docking and Design via Hierarchical Equivariant Refinement](https://mlsanity.com/paper/2207.06616/) (2022)
- [Predicting mutational effects on protein-protein binding via a side-chain diffusion probabilistic model](https://mlsanity.com/paper/2310.19849/) (2023)
- [Active learning for affinity prediction of antibodies](https://mlsanity.com/paper/2406.07263/) (2024)

## Abstract (arXiv)

Accurate prediction and optimization of protein-protein binding affinity is crucial for therapeutic antibody development. Although machine learning-based prediction methods DeltaDelta G are suitable for large-scale mutant screening, they struggle to predict the effects of multiple mutations for targets without existing binders. Energy function-based methods, though more accurate, are time consuming and not ideal for large-scale screening. To address this, we propose an active learning workflow that efficiently trains a deep learning model to learn energy functions for specific targets, combining the advantages of both approaches. Our method integrates the RDE-Network deep learning model with Rosetta's energy function-based Flex ddG to efficiently explore mutants. In a case study targeting HER2-binding Trastuzumab mutants, our approach significantly improved the screening performance over random selection and demonstrated the ability to identify mutants with better binding properties without experimental DeltaDelta G data. This workflow advances computational antibody design by combining machine learning, physics-based computations, and active learning to achieve more efficient antibody development.
